ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 23 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $25,000 | +78.6% | 4,095 | +75.0% | 0.00% | +50.0% |
| Q4 2016 | $14,000 | -22.2% | 2,340 | -7.9% | 0.00% | 0.0% |
| Q3 2016 | $18,000 | +12.5% | 2,540 | +33.3% | 0.00% | 0.0% |
| Q2 2016 | $16,000 | +45.5% | 1,905 | +9.4% | 0.00% | +100.0% |
| Q1 2016 | $11,000 | +10.0% | 1,741 | +46.1% | 0.00% | 0.0% |
| Q4 2015 | $10,000 | – | 1,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |